Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse

Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse

August 24, 2006

Treating malignant tumours is difficult. Doctors have to destroy the tumour, but healthy tissue needs to be preserved. Chemotherapy tends to kill diseased cells, at the same time causing great damage to the body in general. So scientists are looking for ways to destroy only the rampant tumour cells. One way to achieve this is to transport substances inside of microcapsules into the tumour cells and release them there. Researchers led by André Skirtach and Gleb Sukhorukov at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, along with Wolfgang Parak at Ludwig-Maximilian-University in Munich, have now used a laser as a means of opening microcapsules inserted into a tumour cell. The capsules subsequently release their contents, a fluorescent test substance, into the cell. The scientists used a light microscope to monitor how the luminous materials distribute themselves within the cell.

The vehicle that the researchers used was a polymer capsule only a few micrometres in diameter. The walls of the capsules were built from a number of layers of charged polymers, alternating positive and negative. In the laboratory, at least, this is an established way of producing transport containers for medicines, cosmetics, or nutrients, which can also pass through cell membranes. André Skirtach and his colleagues equipped the capsules with a kind of "open sesame". But it didn't require any magic-just nanoparticles made of gold or silver atoms. The scientists mixed together charged metal nanoparticles along with the polymers composing the walls of the vesicle. The tumour cells absorbed the microcapsules and then the scientists aimed an infrared laser at them. Metal nanoparticles are particularly good at absorbing the laser light and transmitting the heat further into their surroundings, heating up the walls. They became so hot that the bonds broke between the polymers and the shell and the capsules eventually opened.




For the time being, the scientists have only been trying out their methods on isolated tumour cells. "In principle, however, active substances could be released into the body this way," says Helmuth Möhwald, director of the Max Planck Institute of Colloids and Interfaces, and one of the participating scientists. This has to (do) with the fact that infrared laser light can penetrate at least one centimetre deep into the tissue. The cells of the body heat up negligibly because laser light at this wavelength is insignificantly absorbed in the tissue. It is the metal particles in the walls of the microcapsules only that absorb the light-even when the microcapsules are in a cell, because the laser affects only them.

Besides using a "thermal opener", the scientists have found another way of making the capsules more stable. They simply heat up the newly created microcapsules very slightly, so that the diameter of the hollow capsules becomes smaller. At the same time, the molecules in their shell are located closer to each other, thickening the capsule walls and better protecting their contents.

There is still, however, a major problem to solve before scientists can use this technology to create medicines which squeeze microcapsules into tumour cells. There is still no way to "steer" the microcapsules. Helmuth Möhwald says, "we have to add some kind of feature to the capsules so that they only recognise the target cells." Only these cells would then allow microcapsules through their membrane.

Max Planck Society for the Advancement of Science



Related Tumour News Articles Tumour News and Current Tumour Events RSS Tumour News and Current Tumour Events RSS
Cancer cells with a long breath: seeking the origin of brain tumors in children
Medulloblastoma is one of the most common and most malignant brain tumours among children and teenagers. These tumours grow very rapidly, and fifty percent of patients in the long term die from the condition.

Monash researchers uncover cancer survival secrets
A team of Monash University researchers has uncovered the role of a family of enzymes in the mutation of benign or less aggressive tumours into more aggressive, potentially fatal, cancers in the human body.

How chemo kills tumours: research to reduce side effects
Dr Stephen Taylor and Karen Gascoigne at the University's Faculty of Life Sciences have taken a new systematic approach to studying anti-mitotic drugs, which are used extensively for breast or ovarian cancer in the UK.

Discovery of a mechanism that regulates cell movement
A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with researchers at the Instituto de Biología Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion.

First worldwide analysis of cancer survival finds wide variation between countries
Cancer survival varies widely between countries according to a worldwide study published online today in Lancet Oncology.* More than 100 investigators contributed to the study.

Scientists from the University of Navarra find 5 genes involved in the metastasis of breast tumours to the lung
The identification of five genes involve in the metastasis of breast tumours to the lung is the principal finding of a scientific team made up of two bodies from the University of Navarra, the Applied Medical Research Centre (CIMA) and the University Hospital of the University of Navarra.

Improving understanding of cell behaviour in breast cancer
The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer.

30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho
Tocilizumab plus methotrexate showed significant clinical improvements in efficacy and safety in patients with moderate to severe rheumatoid arthritis (RA), who had not adequately responded to anti-tumour necrosis factor (anti-TNF) therapy.

Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases
The TRAF1/C5 locus on chromosome 9 has been revealed to play a role in multiple autoimmune diseases including type 1 diabetes and systemic lupus erythematosus (SLE).

Flower power may bring ray of sunshine to cancer sufferers
A mini-protein found in sunflower seeds could be the key to stopping tumors spreading in prostate cancer patients, according to QUT researchers.
More Tumour News Articles
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)



World Health Organization: Tumours of the Breast and Female Genital Organs (Who/IARC Classification of Tumours) (Who/IARC Classification of Tumours)
by Tavassoli

This book is an authoritative, concise reference, prepared by 126 authors from 22 countries. The book will contain more than 800 colour photographs, numerous MRIs, ultrasound images, CT scans, charts and approximately 2000 references. Diagnostic criteria, pathological features and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized...



Pathology And Genetics of Tumours of the Soft Tissues And Bones (World Health Organization Classification of Tumours)
by Who

This book is an authoritative, concise reference, prepared by 147 authors from 28 countries. It contains more than 800 colour photographs, numerous MRIs, ultrasound images, CT scans, charts and approximately 2000 references. Diagnostic criteria, pathological features and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized neoplasms...

Who Classification of Tumours of the Central Nervous System (Who Classfication of Tumours)

WHO Classification of Tumours of the Central Nervous System is the first volume of the 4th Edition of the World Health Organization series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring...



WHO Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (World Health Organization Classification of Tumours)

This new volume in the WHO series on histological and genetic typing of human tumours covers tumours of the kidney, the urinary system, the prostate, the testis and paratesticular tissue and the penis. Each entity is extensively discussed with information on clinicopathological, epidemiological, immunophenotypic and genetic aspects of these diseases. This book is an authoritative, concise...



Pathology And Genetics of Skin Tumours (World Health Organization Classification of Tumours)
by IARC

This volume covers keratinocytic, melanocytic, appendageal, haematopoietic, soft tissue and neural tumours, as well as inherited tumour syndromes. Each entity is extensively discussed with information on clinicopathological, epidemiological, immunophenotypic and genetic aspects of these...



Pathology And Genetics of Head and Neck Tumours (World Health Organization Classification of Tumours)



TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours

The TNM Atlas is designed as an aid for the practical application of the TNM Classification system by illustrating the T and N categories in clear, easily understood graphics suitable for projection as well as individual study. The 5th edition of the TNM Atlas reflects all changes and additions of the recently published 6th edition of the TNM Classification: - numerous new figures to...



Concerning the Origins of Malignant Tumours
by Theodor Boveri

An English translation of Boveri's famous monograph which was first published in Germany in 1914. Written almost a hundred years ago, Theodor Boveri's Zur Frage der Entstehung maligner Tumoren has had a momentous impact on cancer research. In it he argues that malignancy arises as a consequence of chromosomal abnormalities and that multiplication is an inherent property of cells. With astonishing...



International Classification of Rodent Tumours. The Mouse

Regulatory authorities worldwide still depend greatly upon and require long-term animal test results. To improve the reliability of interpretation of such results, a standardized nomenclature for the lesions observed in the tests is essential. Scientists from both academia and industry in many countries have closely cooperated to arrive at a consensus on the descriptions of all the types of...

© 2008 BrightSurf.com